WASHINGTON — The FDA current an oral formula of azacitidine (Onureg) for continued therapy of adults with acute myeloid leukemia (AML) in first remission nevertheless…
WASHINGTON — The FDA current an oral formula of azacitidine (Onureg) for continued therapy of adults with acute myeloid leukemia (AML) in first remission nevertheless…